Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

The thimerosal vote came during the panel’s first meeting since its overhaul by RFK Jr., and as retail investors closely tracked potential shifts in vaccine policy. COVID-19 vaccines from Moderna ...

The recent FDA approval of mNEXSPIKE, Moderna’s next-generation mRNA Covid-19 vaccine, has the same age and risk factor recommendation.

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health Secretary Robert F. Kennedy Jr. fired the entire panel and named eight ...

mNEXSPIKE - The next-generation COVID-19 vaccine was approved for aged 65 and above in May 2025. Spikevax, Moderna's first COVID-19 vaccine, received its initial FDA approval in January 2022.